By further modifying these CAR T cells with an additional receptor that targets IL-8 secreted by tumor cells, there was improved tumor penetrance and persistence by these CAR T cells, leading to complete tumor regression in a U87 murine model [76]. This evidence concerns the gene CXCL8 and neoplasm.